Phillip Frost, M.D. 13D and 13G filings for Niagen Bioscience Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-02 4:03 pm Sale | 2021-02-22 | 13D | Niagen Bioscience Inc NAGE | Phillip Frost, M.D. | 2,351,521 3.800% | -900,000 (-27.68%) | Filing |